We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00176059
First Posted: September 15, 2005
Last Update Posted: May 10, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Heidelberg University
Astellas Pharma Inc
Hoffmann-La Roche
Aventis Pharmaceuticals
Information provided by:
University of Giessen